This website uses cookies to enhance the user experience.
NOVARTIS NORGE AS

NOVARTIS NORGE AS965 599 614

Purchase and sale
Limited company
Nydalsveien 28 0484 OSLO, Norge

NOVARTIS NORGE AS

Vår misjon er å oppdage, utvikle og markedsføre innovative legemidler som forebygger og behandler sykdom, lindrer smerte og forbedrer pasientenes livskvalitet.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Links

Organization

Chairman of the board
Years since formation
30 years
since Feb 20, 1995
Type
Limited company
VAT registered
Yes
Number of employees
89

Ownership

Number of shares and share classes
150
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
1,378,113,774
NOK
Annual total result 2024
42,338,348
NOK
Total equity 2024
332,647,927
NOK
Last update: Jul 14, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
K
KPMG AS
Auditor-
A
AZETS INSIGHT AS
Accountant-
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
150
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
1,378,113,774
1,276,257,015
1,242,904,107
1,423,254,823
Annual Total Result
42,338,348
31,957,791
30,063,079
45,179,427
Total assets
619,699,409
496,675,363
592,491,079
442,289,974
Total liabilities
287,051,483
206,365,786
334,139,295
214,001,268
Total equity
332,647,927
290,309,577
258,351,785
228,288,706

P&L

Year2024202320222021
Total operating income
1,378,113,774
1,276,257,015
1,242,904,107
1,423,254,823
Total operating costs
1,322,694,075
1,234,779,935
1,203,870,440
1,364,441,586
Operating result
55,419,699
41,477,080
39,033,667
58,813,237
Financial income/costs
-1,322,370
-372,906
-360,224
-647,786
Profit before tax
54,097,329
41,104,174
38,673,443
58,165,451
Total tax & extraordinary income/cost
11,758,981
9,146,383
8,610,364
12,986,024
Annual Total Result
42,338,348
31,957,791
30,063,079
45,179,427

Balance overview

Year2024202320222021
Total fixed assets
4,027,496
1,550,583
9,508,338
2,753,646
Total current assets
615,671,913
495,124,780
582,982,741
439,536,328
Total assets
619,699,409
496,675,363
592,491,079
442,289,974
Short term debt
273,182,653
204,435,015
333,794,084
213,551,588
Long term debt
13,868,830
1,930,771
345,211
449,680
Total liabilities
287,051,483
206,365,786
334,139,295
214,001,268
Contributed capital
11,802,649
11,802,649
11,802,649
11,802,649
Retained earnings
320,845,278
278,506,928
246,549,136
216,486,057
Total equity
332,647,927
290,309,577
258,351,785
228,288,706
Total equity and liabilities
619,699,410
496,675,363
592,491,080
442,289,974

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods